[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@bio_clouseau Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::43475268.png) @bio_clouseau M

M posts on X about $tsro, $mrk, $gsk, $srpt the most. They currently have XXXXXX followers and XX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::43475268/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43475268/c:line/m:interactions.svg)

- X Week XXXXXX +266%
- X Month XXXXXX -XX%
- X Months XXXXXXX +30%
- X Year XXXXXXXXX +48%

### Mentions: X [#](/creator/twitter::43475268/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43475268/c:line/m:posts_active.svg)

- X Week X -XX%
- X Month XX -XX%
- X Months XXX +7.20%
- X Year XXX +219%

### Followers: XXXXXX [#](/creator/twitter::43475268/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43475268/c:line/m:followers.svg)

- X Week XXXXXX +0.27%
- X Month XXXXXX +0.52%
- X Months XXXXXX +2%
- X Year XXXXXX +4.90%

### CreatorRank: XXXXXXXXX [#](/creator/twitter::43475268/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::43475268/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::43475268/influence)
---

**Social category influence**
[stocks](/list/stocks)  XXXX%

**Social topic influence**
[$tsro](/topic/$tsro) 5.66%, [$mrk](/topic/$mrk) 3.77%, [$gsk](/topic/$gsk) 3.77%, [$srpt](/topic/$srpt) 1.89%, [$gild](/topic/$gild) 1.89%, [$bmy](/topic/$bmy) 1.89%, [$ptgx](/topic/$ptgx) 1.89%, [$clvs](/topic/$clvs) 1.89%, [$pbyi](/topic/$pbyi) 1.89%, [$vinc](/topic/$vinc) XXXX%

**Top accounts mentioned or mentioned by**
[@bertrandbio](/creator/undefined) [@byamybrown](/creator/undefined) [@jq1234t](/creator/undefined) [@bymadeleinea](/creator/undefined) [@jacobplieth](/creator/undefined) [@syinvesting](/creator/undefined) [@gcbioinv](/creator/undefined) [@davidc85097716](/creator/undefined) [@pilldipp](/creator/undefined) [@joserestonva](/creator/undefined) [@maximus_holla](/creator/undefined) [@marketwirenews](/creator/undefined) [@biopharmaddict](/creator/undefined) [@monkechevarria](/creator/undefined) [@garbageman1985](/creator/undefined)

**Top assets mentioned**
[Merck & Co., Inc. (MRK)](/topic/$mrk) [GSK plc (GSK)](/topic/$gsk) [Sarepta Therapeutics, Inc. (SRPT)](/topic/$srpt) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Protagonist Therapeutics, Inc (PTGX)](/topic/$ptgx)
### Top Social Posts [#](/creator/twitter::43475268/posts)
---
Top posts by engagements in the last XX hours

"This seems like a steal considering $MRK paid lanova close to 600M in in November XX for the pd-1/vegf and 2.7B bio bucks remaining. Though thats only if one thinks there's a very good chance of achieving even 1/3 of the biobucks"  
![@bio_clouseau Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::43475268.png) [@bio_clouseau](/creator/x/bio_clouseau) on [X](/post/tweet/1945155481317646830) 2025-07-15 16:16:20 UTC 19.6K followers, 4567 engagements


"$SRPT gets a platform tech designation on 6/4 for its AAVrh74 viral vector for LGMD 2E/R4 which seems to indicate the viral vector is "well understood" and "utilized by more than one drug without an adverse effect on quality manufacturing or safety". A little more than a month later FDA asks to voluntarily stop all shipments and issues a statement saying Sarepta "refused" the request and also pulls the platform designation just handed a month earlier. A lot of fingers being pointed at SRPT (rightfully)for being far from transparant but the FDA is not without fault either with its new found"  
![@bio_clouseau Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::43475268.png) [@bio_clouseau](/creator/x/bio_clouseau) on [X](/post/tweet/1946508655873995232) 2025-07-19 09:53:22 UTC 19.6K followers, 29.8K engagements


"Interesting comment since $GSK has been mainly spending on late oncology drugs like $TSRO. And most of their other deals have been less extravagant than say $GILD $MRK $BMY. Quite difficult to restart an oncology pipeline after predecessor sells off most of it"  
![@bio_clouseau Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::43475268.png) [@bio_clouseau](/creator/x/bio_clouseau) on [X](/post/tweet/1406935087938146305) 2021-06-21 11:20:39 UTC 19.6K followers, XX engagements


"$PTGX Protagonist unveils 'triple-G' obesity pill but human trials are nearly a year away -"  
![@bio_clouseau Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::43475268.png) [@bio_clouseau](/creator/x/bio_clouseau) on [X](/post/tweet/1940033780141396181) 2025-07-01 13:04:31 UTC 19.6K followers, 3919 engagements


"Probably a few exceptions like $TSRO $SRRA where smaller biotechs have made a very good ROI on oncology discards from larger biotechs/pharma but seem to be more examples like $VINC $PBYI $CLVS where that strategy has failed miserably"  
![@bio_clouseau Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::43475268.png) [@bio_clouseau](/creator/x/bio_clouseau) on [X](/post/tweet/1783812752626049070) 2024-04-26 10:57:56 UTC 19.6K followers, 3930 engagements